A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults
Conclusion:
In this study, the rise in NAD+ levels at day 30 and day 60 of /NADH illustrates the potential of UTHEVER to increase NAD+ levels in cells associated with higher energy levels and anti-aging effects. Increased sensitivity to insulin has also been linked to anti-aging. In addition, the safety and efficacy of oral administration of NMN 300 mg in healthy individuals have been demonstrated, and oral administration of NMN 300 mg does not cause any specific harmful effects in healthy volunteers.
